Real-time enrollment status for this solid tumors with hras alterations clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:38 AM UTC
| NCT Number | NCT06026410 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors With HRAS Alterations |
| Phase | Clinical Trial |
| Target Enrollment | 300 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Kura Oncology, Inc. |
| Last Updated on CT.gov | June 8, 2026 (Jun 8, 2026) |
As of July 13, 2026: Clinical trial NCT06026410 is currently recruiting participants. This clinical trial study for solid tumors with hras alterations is actively seeking new participants at 22 locations across the United States. The study is sponsored by Kura Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06026410 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06026410 was last updated Jun 8, 2026 (June 8, 2026). HelloStudys verifies this status automatically.